A business in context

SYBX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-07-27 · 0001193125-26-352228

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-344789

  3. 8-K · Current report

    Report date 2026-07-27 · 0001193125-26-322160 · Items 1.01,3.03,5.01,7.01,9.01

  4. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-224171

  5. 10-K/A · Annual report

    Report date 2025-12-31 · 0001193125-26-197468

  6. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-104262

  7. 8-K/A · Current report

    Report date 2026-01-16 · 0001193125-26-028333 · Items 3.01,8.01

  8. 8-K · Current report

    Report date 2026-01-16 · 0001193125-26-016040 · Items 3.01

  9. 8-K · Current report

    Report date 2025-12-15 · 0001193125-25-319653 · Items 5.02,5.07,9.01

  10. 8-K · Current report

    Report date 2025-11-21 · 0001193125-25-300824 · Items 3.01

  11. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-280270

  12. DEF 14A · Proxy statement

    Report date 2025-12-15 · 0001193125-25-277747

  13. 4 · Ownership change

    Report date 2025-10-29 · 0001193125-25-260649

  14. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105106

  15. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067081

  16. 10-K/A · Annual report

    Report date 2024-12-31 · 0000950170-25-060786

  17. 4 · Ownership change

    Report date 2025-04-26 · 0000950170-25-060267

  18. 4 · Ownership change

    Report date 2025-04-26 · 0000950170-25-060253

  19. 4 · Ownership change

    Report date 2025-04-02 · 0000950170-25-050478

  20. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-034820

  21. 8-K · Current report

    Report date 2025-02-20 · 0000950170-25-024891 · Items 5.02

  22. 4 · Ownership change

    Report date 2025-02-03 · 0000950170-25-013831

  23. 8-K · Current report

    Report date 2025-01-10 · 0000950170-25-005425 · Items 5.02

  24. 8-K · Current report

    Report date 2024-12-17 · 0000950170-24-139249 · Items 5.02

  25. 8-K · Current report

    Report date 2024-12-04 · 0000950170-24-133381 · Items 5.07,9.01

  26. SC 13G/A · Ownership disclosure

    0001172661-24-005274

  27. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-125567

  28. 8-K · Current report

    Report date 2024-11-12 · 0000950170-24-125523 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2024-12-04 · 0001193125-24-251476

  30. 4 · Ownership change

    Report date 2024-10-29 · 0000950170-24-119194

  31. 8-K · Current report

    Report date 2024-08-08 · 0000950170-24-093291 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-093282

  33. SC 13D/A · Ownership disclosure

    0001072613-24-000508

  34. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000950170-24-059064

  35. 8-K · Current report

    Report date 2024-05-14 · 0000950170-24-059063 · Items 2.02,9.01

  36. 10-K/A · Annual report

    Report date 2023-12-31 · 0000950170-24-049810

  37. SC 13G · Ownership disclosure

    0000921895-24-000872

  38. 4 · Ownership change

    Report date 2024-04-02 · 0000950170-24-041790

  39. 8-K · Current report

    Report date 2024-03-19 · 0000950170-24-034854 · Items 5.02

  40. 10-K · Annual report

    Report date 2023-12-31 · 0000950170-24-033146

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001527599SYNLOGIC, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Mirna Therapeutics, Inc. · former SEC name · 2011-08-23 to 2017-08-25

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$8.0K$8.5K
2023-12-31$3.37M$3.69M
2022-12-31$1.18M$1.35M
2021-12-31$1.75M$2.16M
2020-12-31$545.0K$703.2K
2019-12-31$2.22M$2.90M
2018-12-31$2.52M$3.35M
2017-12-31$2.44M$3.33M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗